Observational Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Erenumab-aooe During Pregnancy (20180172)

First published 14/10/2020

Last updated 22/11/2024

EU PAS number:

EUPAS37499

Study

Ongoing

Download as PDF

Documents

Study protocol

Initial protocol

Protocol-Published Original erenumab 20180172 .pdf

English (5.92 MB - PDF)View document

Study results

Study report

Other information